Embody Receives $2.5 Million Phase II Research Award
Embody, a cultivate(MD) portfolio company, is receiving a $2.5 million Phase II Small Business Innovation Research award through the Defense Advanced Research Projects Agency (DARPA).
Virtual Incision Announces $20 Million Financing
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
Medical Startup Receives FDA Clearance
A medical device startup in the region has received FDA clearance for a new product.
2020 ASAP Meeting
Genesis is proud to be a sponsor of the 2020 ASAP Meeting (Advanced Shoulder ArthroPlasty). This year’s meeting will be held on January 16-18, 2020 in Snowbird, UT.
Ward Detwiler Named To Crain’s Top 40 Under 40
Congratulations to Ward Detwiler, who was just awarded as a Crain’s Top 40 Under 40!
Rob Ball – Keynote Panelist at OMTEC 2019
Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.
Shoulder Innovations Announces Publication of Long Term Data for InSet Glenoid
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.
cultivate(MD) Announces Investment Into HAPPE Spine
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Capital Fund II, LP, funds focused on investments into early stage healthcare companies …
cultivate(MD) Announces Investment Into Embody, Inc.
HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces its investment into …